Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Lonza to Build Biologics CDMO in China Using GE's Prefabricated Factory

publication date: Dec 12, 2018

Lonza Group, a Swiss company that offers CDMO services and lab products, announced plans to partner with GE Healthcare to build a biologics manufacturing facility in Guangzhou, using GE's KUBio platform. Because the prefabricated facility reduces construction/approval times, Lonza expects it will be operational in 2020. Previously, Lonza offered CDMO scale-up and production for APIs in China, also from a Guangzhou facility. The company will hire and train over 160 staff for the new biologics facility. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital